Altered Expression of Cell Cycle Proteins and Prolonged Duration of Cardiac Myocyte Hyperplasia in p27KIP1 Knockout Mice

RA Poolman, JM Li, B Durand, G Brooks - Circulation research, 1999 - Am Heart Assoc
RA Poolman, JM Li, B Durand, G Brooks
Circulation research, 1999Am Heart Assoc
The precise role of cell cycle–dependent molecules in controlling the switch from cardiac
myocyte hyperplasia to hypertrophy remains to be determined. We report that loss of
p27KIP1 in the mouse results in a significant increase in heart size and in the total number of
cardiac myocytes. In comparison to p27KIP1+/+ myocytes, the percentage of neonatal
p27KIP1−/− myocytes in S phase was increased significantly, concomitant with a significant
decrease in the percentage of G0/G1 cells. The expressions of proliferating cell nuclear …
Abstract
—The precise role of cell cycle–dependent molecules in controlling the switch from cardiac myocyte hyperplasia to hypertrophy remains to be determined. We report that loss of p27KIP1 in the mouse results in a significant increase in heart size and in the total number of cardiac myocytes. In comparison to p27KIP1+/+ myocytes, the percentage of neonatal p27KIP1−/− myocytes in S phase was increased significantly, concomitant with a significant decrease in the percentage of G0/G1 cells. The expressions of proliferating cell nuclear antigen, G1/S and G2/M phase–acting cyclins, and cyclin-dependent kinases (CDKs) were upregulated significantly in ventricular tissue obtained from early neonatal p27KIP1−/− mice, concomitant with a substantial decrease in the expressions of G1 phase–acting cyclins and CDKs. Furthermore, mRNA expressions of the embryonic genes atrial natriuretic factor and α-skeletal actin were detectable at significant levels in neonatal and adult p27KIP1−/− mouse hearts but were undetectable in p27KIP1+/+ hearts. In addition, loss of p27KIP1 was not compensated for by the upregulation of other CDK inhibitors. Thus, the loss of p27KIP1 results in prolonged proliferation of the mouse cardiac myocyte and perturbation of myocyte hypertrophy.
Am Heart Assoc